Overall, the findings suggest using caution, not alarm, since most people do well on GLP-1 treatment, says Dr
A similar lower risk for recurrent CUD was observed in patients with and without obesity, though not statistically significant in patients without obesity (Fig
You will be eligible for a refill when you have about 2-3 weeks of medication remaining
For people concerned about muscle quality and energy output during GLP-1-induced weight loss, addressing both pathways simultaneously is a reasonable approach
4 Future challenges 4.1 Mechanistic validation across ocular pathologies Despite progress in understanding molecular pathways such as calcium channel modulation and mitochondrial mitophagy, the relative contributions of these mechanisms to specific diseases remain unclear
When these signals are better balanced, many people find it easier to eat smaller portions, avoid constant snacking, and stay satisfied longer between meals